Short immunomodulatory oligonucleotides
US7354907B2 · kind B2 · utility
22Cited by
7References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2003 |
| Grant date | Apr 8, 2008 |
| Priority date | — |
| Expiry date | Aug 28, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55561
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to modulation of the immune system. More particularly, the invention relates to modulating the immune system through the use of oligonucleotide-derived compounds. The invention provides immunostimulatory agents that are less expensive to make than existing immunostimulatory oligonucleotides. The immunostimulatory agents according to the invention can, in preferred embodiments, cause immune stimulation across species lines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.